Please use this identifier to cite or link to this item:
http://dspace.mediu.edu.my:8181/xmlui/handle/10261/2875| Title: | Pneumococcal LytA Autolysin, a Potent Therapeutic Agent in Experimental Peritonitis-Sepsis Caused by Highly β-Lactam-Resistant Streptococcus pneumoniae |
| Publisher: | American Society for Microbiology |
| Description: | The in vitro and in vivo antipneumococcal activities of the main pneumococcal autolysin (LytA) and Cpl-1, a lysozyme encoded by phage Cp-1, were studied. Intraperitoneal therapy with LytA or high-dose Cpl-1 remarkably reduced peritoneal bacterial counts (>5 log10 CFU/ml) compared with those for the controls. After intravenous injection, LytA was the most effective treatment. This research was supported by grants from the Red Tematica de Investigacion Cooperativa Spanish Pneumococcal Infection Study Network (grant G03/103) (Ministerio de Sanidad y Consumo, Spain) and the program COMBACT Nuevas Dianas para Combatir a las Bacterias Patogenas (grant S-BIO-026-2006) (Consejerıa de Educacion, Comunidad de Madrid, Madrid, Spain). L.H. and G.D.P. received scholarships from the Fundacio´n Conchita Ra´bago; M.G. received a scholarship from the Fondo de Investigaciones Sanitarias, Ministerio de Sanidad y Consumo, Spain. Peer reviewed |
| URI: | http://dspace.mediu.edu.my:8181/xmlui/handle/10261/2875 |
| Other Identifiers: | Antimicrob Agents Chemother. 2007 September; 51(9): 3371–3373 PMCID: 2043201 0066-4804 http://hdl.handle.net/10261/2875 10.1128/AAC.00137-07 |
| Appears in Collections: | Digital Csic |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.